We examined the correlation between sputum colour and the presence of potentially pathogenic
bacteria in acute exacerbations of chronic bronchitis (AECBs). Data were pooled from …

OBJECTIVE To compare the clinical and bacteriological efficacy and the clinical safety of a 1‐day
with a 3‐day regimen of an extended‐release formulation of ciprofloxacin (…

Background. Cystic fibrosis patients have chronic bacterial infections of the respiratory tract,
most commonly Pseudomonas aeruginosa. Although controversial, administration of …

In a prospective, multicenter, randomized trial, the efficacy and safety of a 1-week treatment
regimen of ciprofloxacin otic drops (0.2%), with or without hydrocortisone, or polymyxin B-…

Haemophilus influenzae is the most common bacterial pathogen associated with acute
exacerbations of chronic bronchitis (AECB). This study determined the rate of bacterial …

Background Acute bacterial sinusitis (ABS) is a common infection in clinical practice. Data on
time to bacteriologic eradication after antimicrobial therapy are lacking for most agents, but …

This report focuses on the role of Pseudomonas aeruginosa in complicated urinary tract
infections in a prospective, open-label, multicenter study designed to evaluate the safety and …

CONCLUSIONS: Uncomplicated UTis in males may not be as uncommon as current
literature suggests. Presentation and diagnostic criteria employed in primary care are greatly …

PURPOSE: H. influenzae is the most common pathogen associated with acute bacterial
exacerbations of chronic bronchitis (ABECB). With increasing H. influenzae resistance to …